Valuation : Alcon Inc.

Market Cap 3.46TCr 2.99TCr 2.8TCr 2.55TCr 4.81TCr 3,31100Cr 4.83TCr 33TCr 13TCr 1,67100Cr 13TCr 13TCr 5,54200Cr P/E 2026 *
42.9x
P/E 2027 * 26x
Enterprise Value 3.72TCr 3.2TCr 3TCr 2.74TCr 5.17TCr 3,55400Cr 5.18TCr 36TCr 14TCr 1,79400Cr 14TCr 14TCr 5,94900Cr EV / Sales 2026 *
3.35x
EV / Sales 2027 * 3.07x
Free-Float
97.34%
Yield 2026 *
0.51%
Yield 2027 * 0.58%
1 day-0.96%
1 week-1.53%
Current month+4.55%
1 month+2.48%
3 months+11.95%
6 months-13.40%
Current year-8.50%
1 week 57.5
Extreme 57.5
59.66
1 month 55.28
Extreme 55.28
62.18
Current year 47.8
Extreme 47.8
68.34
1 year 47.8
Extreme 47.8
68.34
3 years 47.8
Extreme 47.8
87
5 years 47.8
Extreme 47.8
87
10 years 38.62
Extreme 38.625
87
Manager TitleAgeSince
Chief Executive Officer 60 01/07/2018
Director of Finance/CFO 58 08/04/2019
Chief Tech/Sci/R&D Officer - 01/01/2025
Director TitleAgeSince
Director/Board Member 60 -
Chairman 70 01/07/2018
Director/Board Member 63 01/02/2019
Date Insider Type Main position Quantity % Market Cap.
07/05/26 Buy 3,000 0.0006%
27/02/26 Sell 15,000 0.0030%
27/02/26 Sell 2,412 0.0005%
Change 5-day change 1-year change 3-year change Capi.($)
-0.96%-1.53% - - 3.46TCr
Average -0.96%
Weighted average by Cap. -0.96%

Financials

2026 *2027 *
Net sales 1.11TCr 955.55Cr 895.92Cr 817.84Cr 1.54TCr 1,06000Cr 1.55TCr 11TCr 4.15TCr 53TCr 4.16TCr 4.07TCr 1,77400Cr 1.18TCr 1.01TCr 951.22Cr 868.33Cr 1.64TCr 1,12500Cr 1.64TCr 11TCr 4.4TCr 57TCr 4.42TCr 4.32TCr 1,88300Cr
Net income 76Cr 66Cr 62Cr 56Cr 106.18Cr 7.3TCr 106.52Cr 732.53Cr 285.81Cr 3.69TCr 286.92Cr 280.68Cr 12TCr 125.89Cr 108.48Cr 101.71Cr 93Cr 174.91Cr 12TCr 175.47Cr 1.21TCr 470.82Cr 6.07TCr 472.66Cr 462.38Cr 20TCr
Net Debt 254.48Cr 219.29Cr 205.6Cr 187.69Cr 353.57Cr 24TCr 354.7Cr 2.44TCr 951.73Cr 12TCr 955.45Cr 934.66Cr 41TCr 144.99Cr 124.94Cr 117.15Cr 106.94Cr 201.45Cr 14TCr 202.09Cr 1.39TCr 542.26Cr 7TCr 544.38Cr 532.54Cr 23TCr
Logo Alcon Inc.
Alcon Inc. is the global leader in the design, manufacture and marketing of ophthalmic care products. Net sales break down by category of products as follows: - ophthalmic surgical products and equipment (55.7%): consumables (52.7% of net sales), implantable products (31%) and other products (16.3%; in particular surgical equipment) for the treatment of cataracts, retinal diseases, glaucoma and refractive errors; - vision care products (44.3%): contact lenses (60.6% of sales) and eye care products (39.4%; eye drops and ophthalmic ointments, etc.). At the end of 2025, the group operated 17 production sites worldwide. Net sales are distributed geographically as follows: Switzerland (0.7%), the United States (45.1%), Japan (5.9%), China (5.5%), and Other (42.8%).
Employees
25,000
Date Price Change Volume
28/26/28 CHF 57.90 -0.96% 7,20,770
27/26/27 CHF 58.46 -0.24% 7,15,307
26/26/26 CHF 58.60 -0.20% 7,25,942
25/26/25 CHF 58.72 -0.34% 7,65,726
24/26/24 CHF 58.92 +0.20% 7,21,280
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
26
Last Close Price
71.66USD
Average target price
91.39USD
Spread / Average Target
+27.52%

Quarterly revenue - Rate of surprise